Targeted delivery of tissue factor to tumor neovasculature for cancer therapy.
Neri
D
D
Deportment of Applied BioSciences, Swiss Federal Institute of Technology, Zurich. neri@pharma.anbi.ethz.ch
D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000235:genetics / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D016503:Drug Delivery Systems; D005353:Fibronectins / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000276:immunology; D051379:Mice; D009369:Neoplasms / Q000098:blood supply / Q000473:pathology / Q000628:therapy*; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D013925:Thromboplastin / Q000008:administration & dosage* / Q000235:genetics
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D005353:Fibronectins; D011993:Recombinant Fusion Proteins; D013925:Thromboplastin